Beijing Tiantan Hospital, Capital Medical University (here in after referred to as Beijing Tiantan Hospital) was founded on August 23, 1956. It is a grade-3class-A hospital with a neurosurgery unit and a characteristic neuroscience cluster, including medical treatment, teaching, research, and prevention. It also offers an Asian clinical, scientific, and teaching base of neurosurgery. Several medical institutions are located in Beijing Tiantan Hospital, including the China National Clinical Research Center for Neurological Diseases, the National Center for Healthcare and Quality Management in Neurological diseases, the China National Medical Licensing Examination Clinical Skill Test Center–Tiantan, the China National Cerebrovascular Disease Prevention and Treatment Office, the World Health Organization Collaborating Center for Research and Training in Neuroscience, the Beijing Institute of Neurosurgery, and the Fifth Clinical Medical College of Capital Medical University.

Since its establishment 62 years ago, it has inherited spirit of "noble medical ethics, persistent excellence, rigorousness and practicality, diligence and honesty" and has adhered to its purpose of "serving patients wholeheartedly." A number of Chinese clinical neuroscientists and leaders have emerged in succession, including Academician Wang Zhongcheng, Academician Zhao Jizong, Professor Dai Jianping, and Professor Wang Yongjun. Over the course of several generations, it suffered with the state and went through a difficult period of development, ultimately becoming China’s leader in clinical neuroscience. At present, the hospital is endowed with three national key disciplines and three national key clinical specialties among which both neurosurgery and neurology took first place in the scientific and technological value of Chinese hospitals in 2017 and 2018. It is credited with an academician of the Chinese Academy of Sciences, two Beijing scholars, a First-batch Young Yangtze River Scholar of the Ministry of Education of the People's Republic of China, three members of the National Special Support Program for the High-Level Personnel Recruitment, and eight members of the Millions of New Century Talents. It won a Highest Science and Technology Award, a First-Class Prize for the State Scientific and Technological Progress Award, and four Second-Class Prizes for the State Scientific and Technological Progress Award. The hospital’s 25 doctoral training majors, 25 master training majors, 70 doctoral advisors, and 142 master's advisors all have been certified.

In response to the national strategic deployment of "noncapital functions of Beijing relief", the hospital promotes the Central Axis Heritage Application work of Beijing City in coordination with the strategic layout of Beijing-Tianjin-Hebei coordinated development. Construction of the new Beijing Tiantan Hospital began in December 2013. It was in trial operation fully on October 6, 2018, and was put into operation officially on January 30, 2019. It is the first large-scale comprehensive grade-3class-A hospital to have fully relocated in Beijing City since the People's Republic of China was founded.

Located at South Fourth Ring Western Road No.119, Fengtai District, the hospital covers an area of 181,581 square meters and a total building area of 352,294 square meters. It has three functional areas, including a medical treatment area, administrative and scientific research area, and cadre healthcare and teaching area. It was endowed with 67 clinical departments, 8 medical and technical departments, 1,650 authorized beds, and 3,210 employees by 2019. According to the general requirement of building an international first-class innovative hospital, it has aimed to reorganize and adjust the development framework of both dominant and basic disciplines with the center of diseases on the basis of the development strategy of "Strong Specialty and Great Comprehensiveness." Regarding patient care, it has gradually addressed development shortcomings of the disciplines, maintained a leading advantage in neuroscience, and stimulated the potential momentum of basic disciplines to better provide high-quality medical service for residents from Southern Beijing as well as for patients from outside the region.

In addition, it adheres to the new development concept of "innovation-driven, talent priority, cooperation, and win-win situation." It has integrated this development strategy into the construction blueprint for the Beijing Science and Technology Innovation Center. First, it implemented requirements related to the National Plan for the Improvement of Medical Service, introduced the concept of intelligent services, and built an intelligent hospital by applying advanced technologies fully, including artificial intelligence (AI), the internet of things, big data, and cloud computing, to provide high-quality, accurate, efficient, and convenient medical service to patients. Second, it has investigated the construction of research hospitals and research wards as a first-level research ward and pilot institution in Beijing City. It established new drug research and development, undertook national and international clinical trials, and contributes to the Beijing G20 initiative. Third, it drove the development of a new biomedicine engine, strengthened innovation and cultivation, and firmly promoted the transformation of new drug and instrument results in the field of nervous system diseases. It has made positive progress in several aspects, including rapid gene typing detection, a new drug (i.e., chlorogenic acid) for gliblyastoma treatment, intervention of high-precision minimally invasive vascular interventional surgery robots, a global first AI-assisted MRI and CT neuroimaging-based diagnosis technology, brain network connectivity AI anesthesia, and clinical syncope diagnosis system. The effects of these innovations have emerged gradually.

Success originates only from aspiration and diligence. The leadership team at Beijing Tiantan Hospital will guide hospital staff to implement the spirit of the Nineteenth National Congress of the CPC under the guidance of Xi Jinping’s “Thought on Socialism with Chinese Characteristics for a New Era.” Following the development strategy of "Strong Specialty and Great Comprehensiveness," it will continue to build the China Neuroscience Innovation Center and the National Clinical Medical Center; implement the medical spirit of "respecting life, saving lives, treating injuries, willingness to serve, and great love"; and fully develop the responsibility of public hospitals to make new and greater contributions to the advancement of a "Healthy Beijing."

Hospital Office

July1, 2019